Stay updated on SB414 PK, PD, Safety in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.

Latest updates to the SB414 PK, PD, Safety in Psoriasis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page appears to retain core study details (conditions, eligibility criteria, interventions, outcomes, locations, and dates) with only cosmetic layout changes between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check40 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference5%

- Check47 days agoChange DetectedAdded version label (v3.1.0); removed multiple drug-safety and regulatory sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, etc.). The net effect is a narrowing of content rather than expansion.SummaryDifference0.6%

- Check62 days agoChange DetectedThe page updated to Revision: v3.0.2 from v3.0.1, indicating a new version. The Back to Top link was removed, a minor UI change.SummaryDifference0.3%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as important topics related to drug safety and counterfeit drugs. The revision number has also been updated to v3.0.0.SummaryDifference2%

Stay in the know with updates to SB414 PK, PD, Safety in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.